A recent paper about correlations of the CALR mutation variant allele frequency (VAF) in patients with myelofibrosis showed an association with a higher VAF of CARL, a lower hemoglobin level and platelet count, higher peripheral blood CD34+ cell counts, the need for cytoreduction therapy, and shorter leukocytosis-free survival. Here, CALR is linked to myelofibrosis.